← Eichor
Condition: Myasthenia Gravis Musk Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myasthenia Gravis Musk

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myast
Phase 3 · 145 location(s) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of M · NCT06463587Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Phase 3 · 84 location(s) · Immunovant Sciences GmbH · NCT07039916Myasthenia Gravis Foundation of America Global MG Patient Registry
Phase N/A · 1 location(s) · Myasthenia Gravis Foundation of America · NCT06617741Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised My
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07570589Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · 40 location(s) · NMD Pharma A/S · NCT06414954
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.